99 related articles for article (PubMed ID: 1274382)
1. Metabolism in rats and man of piromidic acid, a new antibacterial agent.
Sekine Y; Miyamoto M; Hashimoto M; Nakamura K
Xenobiotica; 1976 Mar; 6(3):185-8. PubMed ID: 1274382
[TBL] [Abstract][Full Text] [Related]
2. Studies on the metabolism of the new antidiabetic agent pioglitazone. Identification of metabolites in rats and dogs.
Kiyota Y; Kondo T; Maeshiba Y; Hashimoto A; Yamashita K; Yoshimura Y; Motohashi M; Tanayama S
Arzneimittelforschung; 1997 Jan; 47(1):22-8. PubMed ID: 9037439
[TBL] [Abstract][Full Text] [Related]
3. Studies on the metabolism of d-limonene (p-mentha-1,8-diene). IV. Isolation and characterization of new metabolites and species differences in metabolism.
Kodama R; Yano T; Furukawa K; Noda K; Ide H
Xenobiotica; 1976 Jun; 6(6):377-89. PubMed ID: 969565
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Yoshida K; Itogawa A; Tagawa M; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1095-102. PubMed ID: 8267676
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
Terashita S; Tokuma Y; Fujiwara T; Shiokawa Y; Okumura K; Noguchi H
Xenobiotica; 1987 Dec; 17(12):1415-25. PubMed ID: 3439192
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 4th communication: metabolism in rats and dogs.
Hirota T; Nakamura A; Sugihara K; Morino A
Arzneimittelforschung; 1997 Feb; 47(2):175-81. PubMed ID: 9079237
[TBL] [Abstract][Full Text] [Related]
7. Identification of the urinary metabolites of 14C-bumetanide in the rat and their excretion by rats and dogs.
Kolis SJ; Williams TH; Schwartz MA
Drug Metab Dispos; 1976; 4(2):169-76. PubMed ID: 5262
[TBL] [Abstract][Full Text] [Related]
8. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of alpha-methylfluorene-2-acetic acid (cicloprofen): isolation and identification of metabolites from rat urine.
Lan SJ; Dean AV; Kripalani KJ; Cohen AI
Xenobiotica; 1978 Feb; 8(2):121-31. PubMed ID: 626004
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
11. Metabolism, distribution and excretion of a selective N-methyl-D-aspartate receptor antagonist, traxoprodil, in rats and dogs.
Prakash C; Cui D; Potchoiba MJ; Butler T
Drug Metab Dispos; 2007 Aug; 35(8):1350-64. PubMed ID: 17496205
[TBL] [Abstract][Full Text] [Related]
12. Biotransformation of 3-(2',4',5'-triethoxybenzoyl) propionic acid, a new biliary smooth muscle relaxant with choleretic activity, in rats.
Kobayashi T; Tanayama S; Kanai Y
Xenobiotica; 1978 Sep; 8(9):535-45. PubMed ID: 695697
[TBL] [Abstract][Full Text] [Related]
13. Physiological disposition and metabolic fate of a new antiarrhythmic agent, alpha, alpha-dimethyl-4-(alpha, alpha, beta, beta-tetrafluorophenethyl) benzylamine in the rat, dog, monkey, baboon, and man.
Zacchei AG; Weidner LL; Besselaar GH; Raftery EB
Drug Metab Dispos; 1976; 4(4):387-401. PubMed ID: 8295
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of nisoldipine. III. Biotransformation of nisoldipine in rat, dog, monkey, and man.
Scherling D; Karl W; Ahr G; Ahr HJ; Wehinger E
Arzneimittelforschung; 1988 Aug; 38(8):1105-10. PubMed ID: 2973788
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of MK-499, a class III antiarrhythmic agent, in rats and dogs.
Vickers S; Duncan CA; Slaughter DE; Arison BH; Greber T; Olah TV; Vyas KP
Drug Metab Dispos; 1998 May; 26(5):388-95. PubMed ID: 9571219
[TBL] [Abstract][Full Text] [Related]
16. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
[TBL] [Abstract][Full Text] [Related]
17. Researches on antibacterial and antifungal agents. II - Synthesis of 1-ethyl-1,4-dihydro-4-oxo-7-(1-pyrrolidinyl)quinoline-3-carboxylic acid, a novel highly active, broad-spectrum antibacterial agent related to piromidic acid.
Corelli F; Massa S; Stefancich G; Artico M; Panico S; Simonetti N
Farmaco Sci; 1984 Feb; 39(2):95-109. PubMed ID: 6425079
[TBL] [Abstract][Full Text] [Related]
18. Identification of the metabolites of erythro-9-(2-hydroxy-3-nonyl)hypoxanthine from laboratory animals.
Pfadenhauer EH; Bankert CS; Jensen J; Jones CE; Jenkins EE; McCloskey JA
Drug Metab Dispos; 1984; 12(3):280-4. PubMed ID: 6145553
[TBL] [Abstract][Full Text] [Related]
19. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
